BEXSERO
BEXSERO
Approved
DIN Number
02417030
Drug Class
Human
Market Date
Feb 26, 2014
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02417030
AIG Number0455051001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH09 MENINGOCOCCUS B, MULTICOMPONENT VACCINE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
OUTER MEMBRANE VESICLES (NEISSERIA MENINGITIDIS GROUP B NZ98/254 STRAIN)Active
Strength: 25 MCG / 0.5 ML
Monograph: OUTER MEMBRANE VESICLES (NEISSERIA MENINGITIDIS GROUP B NZ98/254 STRAIN)
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEINActive
Strength: 50 MCG / 0.5 ML
Monograph: RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEINActive
Strength: 50 MCG / 0.5 ML
Monograph: RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEINActive
Strength: 50 MCG / 0.5 ML
Monograph: RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN